Home Trending Stocks American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes...

American Shared Hospital Services (AMS) Stock Continues to Soar Following Unprecedent Volumes Being Traded

American Shared Hospital Services (AMS) stock prices surged by 30.51% as of market close on May 5th, 2021, bringing the price per share up to USD$3.55. Subsequent pre-market fluctuations saw the stock further soar by 30.01%, bringing it up to USD$4.57.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Revenues for Q4 2020

In the company’s most recently disclosed financial reports, AMS reported USD$4.608 million being generated in total revenue over the course of Q4 2020. This represents a 3.7% decrease from reports from the same quarter of the prior year, which saw USD$5.786 in total revenue.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Proton Therapy System Revenue

The company reported the generation of USD$1.403 in revenue from their proprietary proton therapy system. Located at Orlando Health in Florida, the Q4 2020 numbers were 5.6% lower than the numbers reported in Q4 2019. As a moderator of decreasing revenues, decreases in volumes were offset by the period-over-period growth of average reimbursements. Total proton therapy fractions were down 25% as compared to the fourth quarter of 2019, with the period-over-period decrease resulting from the effects of the onset of the COVID pandemic in conjunction with downtime for maintenance.

Gamma Knife Operations Revenue

AMS’s Gamma Knife operations reported revenues of USD$3.205 for the fourth quarter of 2020, representing a 0.8% decrease from the same period of the prior year. With period-over-period decline being attributable to lower volumes across stores, the damage incurred was offset of the acquisition of GKCE by AMS. Gamma Knife procedures were up to 427 in Q4 2020, representing a 3.1% increase in the 414 reported for the same quarter of the previous year, thanks to the GKCE acquisition. Gamma Knife volumes for operating centers in Q4 2020 were down 7.8% compared to Q4 2019.

Increasing Costs and Falling Margins

Because of the attritional effects of the ongoing global Covid-19 pandemic, AMS reported gross margins of USD$1.027 million for Q4 2020, down from the USD$1.441 million reported for Q4 2019. Administrative costs were reported at USD$1.052 million for Q4 2020, up 22.5% from the USD$859,000 reported in Q4 2019. The increase in costs is primarily due to tax and audit expenses increasing, which, in turn, were a result of the GKCE acquisition, stock-based compensation, and software-related expenses.

Operating Loss During the Pandemic

An operating loss of USD$8.543 million was reported for Q4 2020, compared to an operating profit of USD$279,000 reported for Q4 2019. This massive difference is attributable to a pre-tax write-down of impaired assets that totaled USD$8.264 million, accounting for the company’s deposits for two PBRT units, six Gamma Knife units, and associated removal costs. The remaining operating loss of USD$279,000 was primarily due to the ongoing lagging effects of the global pandemic.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AMS

Despite the proliferation of the devastating ensuing since the onset of the global pandemic, AMS has largely been able to avoid the economic catastrophe. With the world hurtling towards universal immunizations, AMS is primed to capitalize on the post-pandemic market. With a consolidation and expansion of their market footprint, current and potential investors are hopeful for significant and sustained returns in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam